Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
3.000
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
3.000
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $15.54 million as of April 28, 2026.
Market Cap
15.54M
Enterprise Value
9.41M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $15.54M, a decrease of -60.60%. That is a compound annual growth rate of -90.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 15.54M | -55.49% |
| Dec 31, 2025 | 34.91M | -11.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precision Optics Corporation | 45.79M |
| Ekso Bionics Holdings | 40.52M |
| Nephros | 34.38M |
| Harvard Bioscience | 30.80M |
| Milestone Scientific | 30.06M |
| Femasys | 23.62M |
| Retractable Technologies | 19.25M |
| Jin Medical International | 17.85M |